Deferred Tax Assets, Operating Loss Carryforwards of Oruka Therapeutics, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary: Oruka Therapeutics, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
Oruka Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2025 was $6,398,000, a 183% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)

Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Oruka Therapeutics, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$6,398,000	+$4,138,000	+183%	31 Dec 2025	10-K	12 Mar 2026	2025	FY
Q4 2024	$2,260,000			31 Dec 2024	10-K	12 Mar 2026	2025	FY
Q4 2013	$39,799,000	+$2,504,000	+6.7%	31 Dec 2013	10-K	20 Mar 2014	2013	FY
Q4 2012	$37,295,000	+$1,544,000	+4.3%	31 Dec 2012	10-K	20 Mar 2014	2013	FY
Q4 2011	$35,751,000			31 Dec 2011	10-K	21 Mar 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.